ClinVar Miner

Submissions for variant NM_000155.4(GALT):c.100T>A (p.Tyr34Asn) (rs111033836)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
EGL Genetic Diagnostics, Eurofins Clinical Diagnostics RCV000726020 SCV000341275 pathogenic not provided 2016-04-18 criteria provided, single submitter clinical testing
Counsyl RCV000022052 SCV000798041 uncertain significance Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase 2018-02-20 criteria provided, single submitter clinical testing
Invitae RCV000022052 SCV000938537 pathogenic Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase 2018-10-23 criteria provided, single submitter clinical testing This sequence change replaces tyrosine with asparagine at codon 34 of the GALT protein (p.Tyr34Asn). The tyrosine residue is highly conserved and there is a large physicochemical difference between tyrosine and asparagine. This variant is not present in population databases (ExAC no frequency). This variant has been observed in combination with another GALT variant in an individual affected with classic galactosemia, and has been shown on the opposite chromosome (in trans) from a pathogenic variant in an affected individual (PMID: 22461411, 25592817). This finding is consistent with autosomal recessive inheritance, and suggests that this variant contributes to disease. ClinVar contains an entry for this variant (Variation ID: 25125). Experimental studies have shown that this missense change impairs enzyme activity (PMID: 22461411, 25592817). For these reasons, this variant has been classified as Pathogenic.
Mendelics RCV000022052 SCV001137801 pathogenic Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase 2019-05-28 criteria provided, single submitter clinical testing
Research and Development, ARUP Laboratories RCV000022052 SCV000042727 pathogenic Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase 2012-12-04 no assertion criteria provided clinical testing Converted during submission to Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.